The increasing phenomenon of inhaling 5MeO dimethyltryptamine in the nation presents significant risks and challenging statutory issues. Currently, 5MeO dimethyltryptamine remains a Schedule Number One substance within this legislation, making its holding and sale prohibited. While vaping delivers the chemical quickly, it also poses unique health r